427 related articles for article (PubMed ID: 18971014)
1. Management of hyperuricemia and gout in CKD.
Gaffo AL; Saag KG
Am J Kidney Dis; 2008 Nov; 52(5):994-1009. PubMed ID: 18971014
[No Abstract] [Full Text] [Related]
2. Gout, diet, and the insulin resistance syndrome.
Fam AG
J Rheumatol; 2002 Jul; 29(7):1350-5. PubMed ID: 12136887
[No Abstract] [Full Text] [Related]
3. The kidney in hyperuricemia and gout.
Mount DB
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):216-23. PubMed ID: 23318701
[TBL] [Abstract][Full Text] [Related]
4. Medical implications of hyperuricemia.
Sachs L; Batra KL; Zimmermann B
Med Health R I; 2009 Nov; 92(11):353-5. PubMed ID: 19999892
[No Abstract] [Full Text] [Related]
5. [PRPP synthetase superactivity].
Kawasugi K; Takeuchi F
Nihon Rinsho; 2003 Jan; 61 Suppl 1():284-7. PubMed ID: 12629732
[No Abstract] [Full Text] [Related]
6. Hyperuricemia and gout.
Lioté F
Curr Rheumatol Rep; 2003 Jun; 5(3):227-34. PubMed ID: 12744816
[TBL] [Abstract][Full Text] [Related]
7. Hyperuricemia and gout: new concepts in diagnosis and management.
Doghramji PP; Wortmann RL
Postgrad Med; 2012 Nov; 124(6):98-109. PubMed ID: 23322143
[TBL] [Abstract][Full Text] [Related]
8. Dietary intake and the risk of hyperuricemia, gout and chronic kidney disease in elderly Taiwanese men.
Chang WC
Aging Male; 2011 Sep; 14(3):195-202. PubMed ID: 20849370
[TBL] [Abstract][Full Text] [Related]
9. Gout and its comorbidities.
Pillinger MH; Goldfarb DS; Keenan RT
Bull NYU Hosp Jt Dis; 2010; 68(3):199-203. PubMed ID: 20969552
[TBL] [Abstract][Full Text] [Related]
10. [Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency].
Sellin L; Kielstein JT; de Groot K
Z Rheumatol; 2015 May; 74(4):322-8. PubMed ID: 25962453
[TBL] [Abstract][Full Text] [Related]
11. [Gout].
Scuiller A; Pascart T; Bernard A; Oehler E
Rev Med Interne; 2020 Jun; 41(6):396-403. PubMed ID: 32201015
[TBL] [Abstract][Full Text] [Related]
12. Hyperuricemia and gout in an employee population.
Thorpe JJ; Daley JM
J Occup Med; 1971 Nov; 13(11):524-34. PubMed ID: 5134350
[No Abstract] [Full Text] [Related]
13. Update on the management of hyperuricemia and gout.
Pillinger MH; Keenan RT
Bull NYU Hosp Jt Dis; 2008; 66(3):231-9. PubMed ID: 18937638
[TBL] [Abstract][Full Text] [Related]
14. [Recent achievements available for the treatment of hyperuricemia and gout. Preface].
Hosoyamada M
Nihon Yakurigaku Zasshi; 2010 Dec; 136(6):315. PubMed ID: 21218662
[No Abstract] [Full Text] [Related]
15. Current world literature.
Curr Opin Rheumatol; 2012 Mar; 24(2):237-44. PubMed ID: 22301869
[No Abstract] [Full Text] [Related]
16. Clinical, humanistic, and economic outcomes of gout.
Brixner DI; Ho MJ
Am J Manag Care; 2005 Nov; 11(15 Suppl):S459-64; quiz S465-8. PubMed ID: 16300460
[TBL] [Abstract][Full Text] [Related]
17. [Hyperuricemia, gout and cardiovascular diseases].
Murray K; Burkard T
Ther Umsch; 2016; 73(3):141-6. PubMed ID: 27008446
[TBL] [Abstract][Full Text] [Related]
18. Understanding treatments for gout.
Cannella AC; Mikuls TR
Am J Manag Care; 2005 Nov; 11(15 Suppl):S451-8; quiz S465-8. PubMed ID: 16300459
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiology of hyperuricemia].
Tomita M; Murayama T; Mizuno S
Nihon Rinsho; 2003 Jan; 61 Suppl 1():178-83. PubMed ID: 12629714
[No Abstract] [Full Text] [Related]
20. Management of primary care issues common to CKD and ESRD patients: a brief primer for the nephrology provider.
Chettiar A
Adv Chronic Kidney Dis; 2014 Jul; 21(4):371-6. PubMed ID: 24969390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
